Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy

PURPOSE: High-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN G3) are rare and heterogeneous malignancies with poor prognosis. Aim of this study was to develop prognosticators identifying those patients that derive the most benefit from currently available systemic therapies. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosery, Vivian, Mika, Stephan, Schmid, Kurt Werner, Reis, Henning, Stuschke, Martin, Treckmann, Jürgen, Markus, Peter, Schumacher, Brigitte, Albers, David, Mende, Bastian, Lahner, Harald, Wiesweg, Marcel, Schuler, Martin, Siveke, Jens T., Kasper, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349702/
https://www.ncbi.nlm.nih.gov/pubmed/36071236
http://dx.doi.org/10.1007/s00432-022-04314-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349702/
https://www.ncbi.nlm.nih.gov/pubmed/36071236
http://dx.doi.org/10.1007/s00432-022-04314-5

Ejemplares similares